Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

Walgreens Boots Alliance / Equity Bottom-Up

<ul><li>Walgreens Boots Alliance reported its Fourth Quarter FY 2024 results amidst significant strategic and operational shifts.</li><li>The quarter was marked by a mix of achievements and challenges, aligning with their previously stated objectives of cost cutting, CapEx reduction, and improvements in working capital, all contributing to a positive cash flow in the quarter.</li><li>Baptista Research looks to evaluate the different factors that could influence the company's price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.</li></ul>

Walgreens Boots Alliance reported its Fourth Quarter FY 2024 results amidst significant strategic and operational shifts.The quarter was marked by a mix of achievements and challenges, aligning with their previously stated objectives of cost cutting, CapEx reduction, and improvements in working capital, all contributing to a positive cash flow in the quarter.Baptista Research looks to evaluate the different factors that could influence the company's price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.

Walgreens Boots Alliance Inc.: Capital Discipline & Store Optimization To Orchestrate A Turnaround? - Major Drivers

<ul><li>Walgreens Boots Alliance recently reported on its performance for the third quarter of Fiscal Year 2024.</li><li>The results presented in this discussion reflect mixed outcomes in various areas of the company’s businesses.</li><li>It is essential to provide a comprehensive view of the positive developments as well as the drawbacks evident in the quarter under review.</li></ul>

Walgreens Boots Alliance recently reported on its performance for the third quarter of Fiscal Year 2024.The results presented in this discussion reflect mixed outcomes in various areas of the company’s businesses.It is essential to provide a comprehensive view of the positive developments as well as the drawbacks evident in the quarter under review.

Walgreens Boots Alliance: Enhancing Digital & Operational Efficiency To Expand Margins! - Major Drivers

<ul><li>The Walgreens Boots Alliance's latest earnings revealed that the company's second-quarter operational results aligned with expectations despite ongoing challenges in the U.S. retail environment.</li><li>The company reported an adjusted EPS of $1.20, reflecting discipline in cost and good execution in the U.S. Retail Pharmacy segment, along with solid performance internationally.</li><li>Baptista Research looks to evaluate the different factors that could influence the company's price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.</li></ul>

The Walgreens Boots Alliance's latest earnings revealed that the company's second-quarter operational results aligned with expectations despite ongoing challenges in the U.S. retail environment.The company reported an adjusted EPS of $1.20, reflecting discipline in cost and good execution in the U.S. Retail Pharmacy segment, along with solid performance internationally.Baptista Research looks to evaluate the different factors that could influence the company's price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.

Walgreens Boots Alliance Inc.: Redefining Relationships & Creating Value with Payers! - Major Drivers

Pan-Asia Catalysts/Events, Quiddity Advisors

Travis Lundy

Pan-Asia Catalysts/Events

Quiddity Advisors

Event-Driven

<ul>
<li>On 31 January, <a href="https://www.smartkarma.com/entities/walmart-inc" target="_blank" data-smartkarma-citation="entities:11134:1" rel="noopener">Walmart (WMT US)</a> announced a 3:1 stock split. For cognoscenti, that meant a Dow Jones Industrial Avg might be in the offing.</li>
<li>The last change to the index was in Aug-2020, spurred by the 4:1 split for <a href="https://www.smartkarma.com/entities/apple-inc" target="_blank" data-smartkarma-citation="entities:666:1" rel="noopener">Apple (AAPL US)</a>. This time, the likely deletion candidate was <a href="https://www.smartkarma.com/entities/walgreens-boots-alliance-inc" target="_blank" data-smartkarma-citation="entities:1118:1" rel="noopener">Walgreens Boots Alliance (WBA US)</a>. </li>
<li>Indeed, last week, the Index Keepers announced <a href="https://www.smartkarma.com/entities/amazon-com-inc" target="_blank" data-smartkarma-citation="entities:409:1" rel="noopener">Amazon.com Inc (AMZN US)</a> would replace Walgreens Boots Alliance on 26 Feb (i.e. WBA would be booted on the close of 23 Feb).</li>
</ul>


On 31 January, Walmart (WMT US) announced a 3:1 stock split. For cognoscenti, that meant a Dow Jones Industrial Avg might be in the offing.
The last change to the index was in Aug-2020, spurred by the 4:1 split for Apple (AAPL US). This time, the likely deletion candidate was Walgreens Boots Alliance (WBA US). 
Indeed, last week, the Index Keepers announced Amazon.com Inc (AMZN US) would replace Walgreens Boots Alliance on 26 Feb (i.e. WBA would be booted on the close of 23 Feb).


Walgreens Boots Alliance (WBA US) - How Do Dow Jones Deletes Do Historically?

<ul><li>Walgreens Boots Alliance surpassed Wall Street's revenue and earnings expectations, showcasing resilience in a challenging US retail environment.</li><li>This achievement reflects the adept execution and cost discipline in US Retail Pharmacy, sustained robust performance internationally, and progress in US Healthcare profitability initiatives.</li><li>While encountering macroeconomic difficulties and acknowledging structural challenges, Walgreens' management underscores the strategic moves in progress.</li></ul>

Walgreens Boots Alliance surpassed Wall Street's revenue and earnings expectations, showcasing resilience in a challenging US retail environment.This achievement reflects the adept execution and cost discipline in US Retail Pharmacy, sustained robust performance internationally, and progress in US Healthcare profitability initiatives.While encountering macroeconomic difficulties and acknowledging structural challenges, Walgreens' management underscores the strategic moves in progress.

Walgreens Boots Alliance Inc.: The Health & Retail Revolution – Unveiling Their Path To Future Growth! - Major Drivers

United States

Walgreens Boots Alliance, Inc., operates retail drugstores that offer a wide variety of prescription and non-prescription drugs as well as general goods. Walgreens' also offers health services, including primary and acute care, wellness, pharmacy and disease management services and health and fitness.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Walgreens Boots Alliance (WBA US)

Walgreens Boots Alliance Inc.: Capital Discipline & Store Optimization To Orchestrate A Turnaround? - Major Drivers

Walgreens Boots Alliance reported its Fourth Quarter FY 2024 results amidst significant strategic and operational shifts. The quarter was marked...

Baptista Research

Walgreens Boots Alliance: Enhancing Digital & Operational Efficiency To Expand Margins! - Major Drivers

Walgreens Boots Alliance recently reported on its performance for the third quarter of Fiscal Year 2024. The results presented in this discussion...

Baptista Research

Walgreens Boots Alliance Inc.: Redefining Relationships & Creating Value with Payers! - Major Drivers

The Walgreens Boots Alliance's latest earnings revealed that the company's second-quarter operational results aligned with expectations despite...

Baptista Research